Edition:
United States

Teleflex Inc (TFX.N)

TFX.N on New York Stock Exchange

237.06USD
21 Sep 2017
Change (% chg)

-- (--)
Prev Close
$237.06
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
66,793
52-wk High
$240.91
52-wk Low
$136.64

Latest Key Developments (Source: Significant Developments)

Vascular Solutions shareholders approve acquisition by Teleflex
Thursday, 16 Feb 2017 10:30am EST 

Vascular Solutions Inc : Vascular Solutions shareholders approve acquisition by Teleflex . Vascular Solutions Inc - Transaction is expected to close on February 17, 2017 .Vascular Solutions Inc- Proposal to adopt agreement and plan of merger was approved by shareholders owning approximately 99.2% of shares voted.  Full Article

Teleflex receives FDA 510(K) clearance for its Arrow VPS Rhythm(Tm) device
Tuesday, 10 Jan 2017 06:45am EST 

Teleflex Inc :Teleflex (TFX) receives FDA 510(K) clearance for its Arrow VPS rhythm(tm) device with optional tiptracker(tm) technology.  Full Article

Teleflex says in connection with termination of merger agreement, Vascular Solutions may be required to pay Teleflex a termination fee of $35 mln
Friday, 2 Dec 2016 05:32pm EST 

Teleflex Inc :Teleflex - In connection with termination of merger agreement, Vascular Solutions may be required to pay Teleflex a termination fee of $35 million.  Full Article

Teleflex Inc to buy Vascular Solutions for $1 bln
Friday, 2 Dec 2016 06:46am EST 

Teleflex Inc : Teleflex incorporated to acquire Vascular Solutions . Teleflex Inc - transaction valued at approximately $1.0 billion. . Teleflex Inc - Teleflex will acquire all of issued and outstanding shares of Vascular Solutions common stock for $56.00 per share, in cash . Boards of directors of both teleflex and Vascular Solutions have unanimously approved transaction . Teleflex Inc - expects acquisition to provide approximately $0.50 in adjusted earnings per share accretion in fiscal year 2018 . Teleflex Inc - anticipates generating synergies of between $40 million to $45 million by fiscal year 2019 from deal . Teleflex Inc - expect deal to generate incremental revenue growth and accretion to adjusted margins, adjusted earnings per share beginning in 2017 . Teleflex Inc - commitment letter from JP Morgan Chase bank for a new $750 million senior unsecured bridge facility in connection with planned deal .Teleflex - plans to finance deal at closing through combination of availability under its revolving credit facility, new secured term loan facility.  Full Article

Teleflex Q3 adjusted earnings per share $1.80 from continuing operations
Thursday, 27 Oct 2016 06:30am EDT 

Teleflex Inc : Teleflex reports third quarter 2016 results . Reaffirms fy 2016 gaap earnings per share view $5.34 to $5.41 from continuing operations . Q3 adjusted earnings per share $1.80 from continuing operations . Q3 gaap earnings per share $1.40 from continuing operations . Q3 revenue $455.6 million versus i/b/e/s view $461.8 million . Q3 earnings per share view $1.78 -- Thomson Reuters I/B/E/S . Updated 2016 guidance ranges for gaap revenue growth to 2.4% to 2.8% and constant currency revenue growth to 3.4% to 3.8% . Increased 2016 guidance range for adjusted diluted eps from $7.20 to $7.32 to $7.25 to $7.34 .Fy2016 earnings per share view $7.32, revenue view $1.88 billion -- Thomson Reuters I/B/E/S.  Full Article

Teleflex Q2 GAAP EPS $1.25 from cont ops
Thursday, 28 Jul 2016 06:30am EDT 

Teleflex Inc : Reported revenue growth of 3.0% to 4.0% and constant currency revenue growth of 5.0% to 6.0% . FY 2016 earnings per share view $7.24, revenue view $1.88 billion -- Thomson Reuters I/B/E/S . Teleflex reports second quarter 2016 results . Q2 adjusted earnings per share $1.89 from continuing operations . Q2 gaap earnings per share $1.25 from continuing operations . Q2 revenue $473.6 million versus I/B/E/S view $468.4 million . Sees FY 2016 revenue up 3 to 4 percent . Q2 earnings per share view $1.74 -- Thomson Reuters I/B/E/S . Says raised 2016 guidance range for GAAP diluted EPS from $5.32 to $5.37 to $5.34 to $5.41 .Says raised 2016 guidance range for adjusted diluted EPS from $7.10 to $7.25 to $7.20 to $7.32.  Full Article

Teleflex prices $400 million worth senior notes
Wednesday, 11 May 2016 07:01pm EDT 

Teleflex Inc : Priced its offering of $400.0 million aggregate principal amount of 4.875% senior notes due 2026 . Says intends to use net proceeds from offering to repay approximately $393.0 million of borrowings under its revolving credit facilit .Teleflex incorporated announces pricing of $400 million senior notes offering.  Full Article

Teleflex Inc announces public offering of $400 mln senior notes
Wednesday, 11 May 2016 08:31am EDT 

Teleflex Inc : Registered public offering of $400.0 million aggregate principal amount of senior notes due 2026 . Intends to use net proceeds from offering to repay approximately $393.0 million of borrowings under its revolving credit facility .Teleflex incorporated announces public offering of $400 million of senior notes.  Full Article

Teleflex Inc announces quarterly dividend
Monday, 2 May 2016 06:45am EDT 

Teleflex Inc:Says Board of Directors declared a quarterly cash dividend of $0.34 per share of common stock.Dividend is payable June 15, 2016 to shareholders of record date as on May 16, 2016.  Full Article

Teleflex Inc says worldwide recall of ARROW International Intra-Aortic Balloon Catheter Kits and Percutaneous Insertion Kits - Reuters
Friday, 11 Mar 2016 06:52am EST 

Teleflex Inc:Announces worldwide recall of arrow international intra-aortic balloon catheter kits and percutaneous insertion kits - RTRS.FDA has classified the recall of arrow international intra-aortic balloon catheter kits and percutaneous insertion kits as a class i recall.On 9-February-2016, Teleflex initiated worldwide recall of 47,140 units distributed throughout the United States and globally.Says at the time of February 9 recall, there were 13 adverse events reported; including 6 serious injuries and 1 death.  Full Article

Device maker Teleflex boosts urology business with NeoTract buy

Medical device maker Teleflex Inc said on Tuesday it would buy privately held NeoTract Inc in its second billion-dollar deal in the past nine months, to strengthen its portfolio of urology devices.